195 related articles for article (PubMed ID: 3983361)
21. Decorporation of Pu/Am Actinides by Chelation Therapy: New Arguments in Favor of an Intracellular Component of DTPA Action.
Grémy O; Laurent D; Coudert S; Griffiths NM; Miccoli L
Radiat Res; 2016 Jun; 185(6):568-79. PubMed ID: 27195610
[TBL] [Abstract][Full Text] [Related]
22. Radium retention in mature beagles injected at 5 years of age.
Lloyd RD; Bruenger FW; Jones CW; Taylor GN; Mays CW
Radiat Res; 1983 Apr; 94(1):210-6. PubMed ID: 6856767
[TBL] [Abstract][Full Text] [Related]
23. The efficacy of DFO-HOPO, DTPA-DX and DTPA for enhancing the excretion of plutonium and ameriicum from the rat.
Stradling GN; Gray SA; Moody JC; Hodgson A; Raymond KN; Durbin PW; Rodgers SJ; White DL; Turowski PN
Int J Radiat Biol; 1991 May; 59(5):1269-77. PubMed ID: 1675243
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of Zn-DTPA in removing plutonium from the human body.
Ohlenschläger L
Health Phys; 1976 Feb; 30(2):249-50. PubMed ID: 1245431
[No Abstract] [Full Text] [Related]
25. Enhanced decorporation of plutonium by DTPA encapsulated in small PEG-coated liposomes.
Phan G; Le Gall B; Grillon G; Rouit E; Fouillit M; Benech H; Fattal E; Deverre JR
Biochimie; 2006 Nov; 88(11):1843-9. PubMed ID: 16860919
[TBL] [Abstract][Full Text] [Related]
26. Reducing the cancer risk of 239Pu by chelation therapy.
Jones CW; Mays CW; Taylor GN; Lloyd RD; Packer SM
Radiat Res; 1986 Sep; 107(3):296-306. PubMed ID: 3749464
[TBL] [Abstract][Full Text] [Related]
27. In vitro and in vivo assessment of plutonium speciation and decorporation in blood and target retention tissues after a systemic contamination followed by an early treatment with DTPA.
Sérandour AL; Grémy O; Fréchou M; Renault D; Poncy JL; Fritsch P
Radiat Res; 2008 Aug; 170(2):208-15. PubMed ID: 18666819
[TBL] [Abstract][Full Text] [Related]
28. Decorporation of plutonium by pulmonary administration of Ca-DTPA dry powder: a study in rat after lung contamination with different plutonium forms.
Sérandour AL; Tsapis N; Gervelas C; Grillon G; Fréchou M; Deverre JR; Bénech H; Fattal E; Fritsch P; Poncy JL
Radiat Prot Dosimetry; 2007; 127(1-4):472-6. PubMed ID: 17562654
[TBL] [Abstract][Full Text] [Related]
29. Efficacies of LICAM(C) and DTPA for the decorporation of inhaled transportable forms of plutonium and americium from the rat.
Stradling GN; Stather JW; Gray SA; Moody JC; Ellender M; Hodgson A
Hum Toxicol; 1986 Mar; 5(2):77-84. PubMed ID: 3514430
[TBL] [Abstract][Full Text] [Related]
30. The distribution and retention of plutonium, americium and uranium in CBA/H mice.
Ellender M; Haines JW; Harrison JD
Hum Exp Toxicol; 1995 Jan; 14(1):38-48. PubMed ID: 7748615
[TBL] [Abstract][Full Text] [Related]
31. Comparison of the effectiveness of CaDTPA and ZnDTPA in removing 241 Am from the rat.
Seidel A
Radiat Res; 1973 May; 54(2):304-15. PubMed ID: 4703890
[No Abstract] [Full Text] [Related]
32. Essential trace metal concentrations in beagle liver and bone tissue after prolonged Zn-DTPA treatment.
Jones CW; Mays CW; Taylor GN
Health Phys; 1989 Feb; 56(2):223-7. PubMed ID: 2917850
[No Abstract] [Full Text] [Related]
33. [Removal of monomeric 239Pu from bones and liver by liposome-encapsulated pentacin].
Smirnov AA; Beliaev IK; Ivannikov AT; Il'in LA
Biull Eksp Biol Med; 1985 Oct; 100(10):431-3. PubMed ID: 4052611
[TBL] [Abstract][Full Text] [Related]
34. Structure of a single model to describe plutonium and americium decorporation by DTPA treatments.
Fritsch P; Sérandour AL; Grémy O; Phan G; Tsapis N; Fattal E; Benech H; Deverre JR; Poncy JL
Health Phys; 2010 Oct; 99(4):553-9. PubMed ID: 20838098
[TBL] [Abstract][Full Text] [Related]
35. Radiation dose rates to the proximal humerus of growing beagles injected with 239Pu.
Bruenger FW; Smith JM; Atherton DR; Miller SC; Jee WS; Stevens W
Radiat Res; 1984 Feb; 97(2):302-17. PubMed ID: 6695051
[TBL] [Abstract][Full Text] [Related]
36. Removal of polymeric plutonium from dogs with DTPA and glucan.
Rosenthal MW; Lindenbaum A; Baxter DW; Kalesperis GS; Moretti ES; Russell JJ
Radiat Res; 1975 Aug; 63(2):253-61. PubMed ID: 1096228
[No Abstract] [Full Text] [Related]
37. Use of DTPA for increasing the rate of elimination of plutonium-238 and americium-241 from rodents after their inhalation as the nitrates.
Stather JW; Stradling GN; Gray SA; Moody J; Hodgson A
Hum Toxicol; 1985 Nov; 4(6):573-82. PubMed ID: 4077069
[TBL] [Abstract][Full Text] [Related]
38. Simplified structure of a new model to describe urinary excretion of plutonium after systemic, liver or pulmonary contamination of rats associated with Ca-DTPA treatments.
Fritsch P; Sérandour AL; Grémy O; Phan G; Tsapis N; Abram MC; Renault D; Fattal E; Benech H; Deverre JR; Poncy JL
Radiat Res; 2009 Jun; 171(6):674-86. PubMed ID: 19580474
[TBL] [Abstract][Full Text] [Related]
39. DTPA therapy of 241Am from a simulated wound site.
Lloyd RD; Taylor GN; Maya CW; McFarland SS; Atherton DR
Health Phys; 1975 Nov; 29(5):808-11. PubMed ID: 1193906
[No Abstract] [Full Text] [Related]
40. Salicylic acid failed to increase the efficacy of Ca-DTPA in the decorporation of plutonium and americium.
Jones CW; Lloyd RD; Mays CW
Radiat Res; 1980 Oct; 84(1):149-51. PubMed ID: 7454978
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
